66 filings
8-K
BIOR
Biora Therapeutics Inc
15 May 24
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:10pm
8-K
BIOR
Biora Therapeutics Inc
2 Apr 24
Entry into a Material Definitive Agreement
4:48pm
8-K
BIOR
Biora Therapeutics Inc
26 Mar 24
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
4:10pm
8-K
BIOR
Biora Therapeutics Inc
11 Mar 24
Entry into a Material Definitive Agreement
8:11am
8-K
BIOR
Biora Therapeutics Inc
16 Jan 24
Biora Therapeutics Provides Outlook for 2024
5:20pm
8-K
ncozl32i7r2
18 Dec 23
Transaction results in nearly 60% reduction in net debt and brings $16.7 million in new capital for the company
8:06am
8-K
d4phzz6faeo431g5k50l
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
5yt491ar37 6p5ef
1 Dec 23
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination
6:06am
8-K
tykjgc1ban3a7nw
13 Nov 23
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:10pm
8-K
icsh9o140jseswhz
13 Oct 23
Unregistered Sales of Equity Securities
6:04am
8-K
sy2 z62ba
11 Oct 23
Unregistered Sales of Equity Securities
6:01am
8-K
k019qu
6 Oct 23
Entry into a Material Definitive Agreement
5:19pm
8-K
tlmkl35t ksr0wclhdp
19 Sep 23
Transaction results in a debt reduction of $50 million for the company
8:06am
8-K
ro34f8g
14 Aug 23
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
12:00am
8-K
xq1dyy7q
15 Jun 23
Departure of Directors or Certain Officers
4:30pm
8-K
c6e7bzj5i0ck
14 Jun 23
Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-market Under Nasdaq Rules
4:11pm
8-K
pive88x699uzpaci
8 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
scjt27lx1ol981imgbsc
15 May 23
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
5pqaw
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
o4891
30 Mar 23
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
4:06pm